Form 38.5(a) (EPT/RI)
Â
FORMÂ 38.5(a)
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ CONNECTEDÂ EXEMPTÂ PRINCIPALÂ TRADERSÂ WITHÂ RECOGNISEDÂ INTERMEDIARYÂ STATUSÂ ANDÂ DEALINGÂ INÂ AÂ CLIENT-SERVINGÂ CAPACITY
Â
1.      KEY INFORMATION
Â
Name of exempt principal trader | Citigroup Global Markets Limited |
Company dealt in | UDG Healthcare plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 28 July 2021 |
Â
2.       DEALINGS (Note 2)
Â
(a)     Purchases and sales
Â
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
49,666 | GBP 10.7900 | GBP 10.7700 |
Â
Â
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
25,666 | GBP 10.7900 | GBP 10.7700 |
Â
Â
(b)     Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) GBP |
TRS | Increasing Short Position | 11,423 | 10.7900 |
TRS | Increasing Short Position | 10,718 | 10.7850 |
TRS | Increasing Short Position | 1,839 | 10.7800 |
TRS | Increasing Short Position | 20 | 10.7700 |
Â
(c)     Options transactions in respect of existing relevant securities
Â
Â
(i)      Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
 |  |  |  |  |  |  |
Â
Â
(ii)Â Â Â Â Â Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
 |  |  |
Â
Â
3.     OTHER INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to theÂ
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisitionÂ
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Â
Â
Â
Â
Â
Â
Date of disclosure | 29 July 2021 |
Contact name | Damian Flanagan |
Telephone number | 00 44 (0) 2890409676 |
Name of offeree/offeror with which connected | Nenelite Limited -Â Â a company controlled by Clayton, Dubilier & Rice, LLC |
Nature of connection (Note 6) | Financial Advisor |
Â
Â
Â
Â
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.